Mesoblast (MESO) Leases (2019 - 2025)
Mesoblast recorded quarterly Leases of $6.5 million in Q4 2025, up 57.39% quarter-over-quarter from $4.1 million in Q2 2025, and up 24.37% year-over-year from $5.2 million in Q4 2024.
Mesoblast's Leases history runs 7 years deep, the most recent figure standing at $6.5 million for Q4 2025.
- In Q4 2025, Leases rose 24.37% year-over-year to $6.5 million; the TTM figure through Dec 2025 stood at $6.5 million (up 24.37% YoY), while the FY2025 annual figure was $4.1 million, up 50.84% from the prior year.
- Leases came in at $6.5 million for Q4 2025 at Mesoblast, up from $4.1 million in the prior quarter.
- In the past five years, Leases ranged from a high of $9.1 million in Q2 2021 to a low of $2.7 million in Q2 2024.
- A 5-year average of $6.5 million and a median of $6.6 million in 2022 frame the typical range for Leases.
- Across the five-year window, Leases sank 46.79% in 2024 and surged 50.84% in 2025, its largest moves.
- Mesoblast's Leases stood at $9.0 million in 2021, then declined by 26.96% to $6.6 million in 2022, then plunged by 34.39% to $4.3 million in 2023, then rose by 20.47% to $5.2 million in 2024, then grew by 24.37% to $6.5 million in 2025.
- According to Business Quant data, Leases over the past three periods registered $6.5 million, $4.1 million, and $5.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | 6.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.49 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 5.64 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Sep 30, 2022 | 7.73 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 8.36 Mn |
| Dec 31, 2021 | 9.03 Mn |
| Sep 30, 2021 | 8.49 Mn |
| Jun 30, 2021 | 9.12 Mn |
| Mar 31, 2021 | 7.25 Mn |
| Dec 31, 2020 | 7.18 Mn |
| Sep 30, 2020 | 8.04 Mn |
| Jun 30, 2020 | 7.98 Mn |
| Mar 31, 2020 | 7.48 Mn |
| Dec 31, 2019 | 8.04 Mn |
| Sep 30, 2019 | 4.23 Mn |